BioCentury | Apr 9, 2021
Deals
April 8 Quick Takes: Hologic buying Mobidiag for nearly $800M; plus Biogen-Bio-Thera, Dicerna royalty sale, a SPAC for LumiraDx, Cidara-Janssen and Chi-Med’s $100M
...This article has been updated to reflect that Dicerna is eligible for $60 million in milestones...
...in Phase III testing.Dicerna sells Oxlumo royalty rightsRoyalty Pharma plc (NASDAQ:RPRX) acquired the royalty interest of Dicerna Pharmaceuticals Inc....
...a 2020 non-exclusive IP deal between Dicerna and Alnylam related to the companies’ PH programs. Dicerna...
...in Phase III testing.Dicerna sells Oxlumo royalty rightsRoyalty Pharma plc (NASDAQ:RPRX) acquired the royalty interest of Dicerna Pharmaceuticals Inc....
...a 2020 non-exclusive IP deal between Dicerna and Alnylam related to the companies’ PH programs. Dicerna...